NCT06653010 2026-01-16
Wondercel-UWD1
Wondercel Biotech (ShenZhen)
Phase EARLY_PHASE1 Recruiting
Clinical Trials
8 trialsNCT07343791 2026-01-15
Efficacy and Safety Study of DC-CIK Cell Therapy Combined With Epaloliposide, Vortexil, and Regorafenib as Third-line Treatment for Advanced Colorectal Cancer.
Jinling Hospital, China
Phase EARLY_PHASE1 Recruiting
NCT07328087 2026-01-09
COLONYVAQâ„¢-CRC
Biogenea Pharmaceuticals Ltd.
Phase EARLY_PHASE1 Recruiting
NCT07167446 2025-10-22
Neuroprotective Potential of Cannabidiol (CBD) in Preventing Oxaliplatin (Ox)-Induced Neuropathy
Fox Chase Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT07050394 2025-07-03
A Dose-Expansion Trial of Intravenous HNF4α srRNA for Unresectable or Metastatic Colorectal Cancer
Shanghai Changzheng Hospital
Phase EARLY_PHASE1 Recruiting
NCT06675513 2025-05-20
Autologous CAR-T Cells (WD-01) for Metastatic Colorectal Cancer
Wondercel Biotech (ShenZhen)
Phase EARLY_PHASE1 Recruiting
NCT06621173 2025-04-24
A Clinical Trial Evaluating the Safety and Efficacy of Intravenous HNF4α SrRNA in Treating Metastatic CRC Patients
Shanghai Changzheng Hospital
Phase EARLY_PHASE1 Recruiting
NCT06937567 2025-04-22
CDH17 CAR-T Therapy in Advanced Malignant Solid Tumors
Zhejiang University
Phase EARLY_PHASE1 Recruiting